• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

未选择的携带种系V832M突变的韩国胃癌患者的频率及临床特征

Frequency and Clinical Characteristics of Unselected Korean Gastric Cancer Patients with a Germline V832M Mutation.

作者信息

Shin Saeam, Kim Yoonjung, Lee Jin Kyung, Lee Kyung-A

机构信息

Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea.

Department of Laboratory Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Korea.

出版信息

J Cancer. 2020 Jan 1;11(1):208-212. doi: 10.7150/jca.36513. eCollection 2020.

DOI:10.7150/jca.36513
PMID:31892987
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6930413/
Abstract

Germline mutations in are associated with hereditary and early onset- diffuse gastric cancer. However, the frequency of germline mutation in unselected gastric cancer cases is not well established. The aim of this study was to investigate the frequency and clinical characteristics of germline V832M mutation carriers in unselected Korean gastric cancer cases. Direct sequencing was performed to determine the presence of V832M in 305 unselected Korean gastric cancer patients. Lauren's histologic type, family history of gastric cancer, and age of cancer diagnosis were compared between V832M carriers and non-carriers. In the study population, seven gastric cancer patients (7/305, 2.29%) were found to have the V832M mutation. The V832M mutation carrier state was not significantly associated with phenotypes including Lauren's histologic type, family history of gastric cancer, age of cancer diagnosis, and other cancer history in a patient. This study demonstrates that the germline V832M mutation is common in sporadic, late onset, and intestinal type gastric cancer as well as familial, early onset, and diffuse type gastric cancer. Our finding suggests that guidelines for managing mutation carriers should be refined through additional data on penetration according to mutation type in sporadic cases.

摘要

种系突变与遗传性和早发性弥漫性胃癌相关。然而,在未选择的胃癌病例中种系突变的频率尚未明确。本研究的目的是调查在未选择的韩国胃癌病例中种系V832M突变携带者的频率和临床特征。对305例未选择的韩国胃癌患者进行直接测序以确定V832M的存在。比较了V832M携带者和非携带者之间的劳伦组织学类型、胃癌家族史以及癌症诊断年龄。在研究人群中,发现7例胃癌患者(7/305,2.29%)存在V832M突变。V832M突变携带者状态与包括劳伦组织学类型、胃癌家族史、癌症诊断年龄以及患者的其他癌症病史等表型无显著相关性。本研究表明,种系V832M突变在散发性、晚发性和肠型胃癌以及家族性、早发性和弥漫型胃癌中均常见。我们的发现表明,应根据散发病例中的突变类型通过更多关于外显率的数据来完善管理突变携带者的指南。

相似文献

1
Frequency and Clinical Characteristics of Unselected Korean Gastric Cancer Patients with a Germline V832M Mutation.未选择的携带种系V832M突变的韩国胃癌患者的频率及临床特征
J Cancer. 2020 Jan 1;11(1):208-212. doi: 10.7150/jca.36513. eCollection 2020.
2
Germline CDH1 mutations are a significant contributor to the high frequency of early-onset diffuse gastric cancer cases in New Zealand Māori.种系CDH1突变是新西兰毛利人早发性弥漫性胃癌病例高发的一个重要因素。
Fam Cancer. 2019 Jan;18(1):83-90. doi: 10.1007/s10689-018-0080-8.
3
Germline mutations in E-cadherin do not explain association of hereditary prostate cancer, gastric cancer and breast cancer.E-钙黏蛋白的种系突变并不能解释遗传性前列腺癌、胃癌和乳腺癌之间的关联。
Int J Cancer. 2002 Apr 20;98(6):838-43. doi: 10.1002/ijc.10258.
4
E-cadherin genetic screening and clinico-pathologic characteristics of early onset gastric cancer.E-钙黏蛋白基因筛查与早发性胃癌的临床病理特征。
Eur J Cancer. 2011 Mar;47(4):631-9. doi: 10.1016/j.ejca.2010.10.011. Epub 2010 Nov 22.
5
CDH1/E-cadherin germline mutations in early-onset gastric cancer.早发性胃癌中的CDH1/E-钙黏蛋白种系突变
J Med Genet. 2006 Nov;43(11):867-72. doi: 10.1136/jmg.2006.043133. Epub 2006 Jun 26.
6
The E-cadherin gene (CDH1) variants T340A and L599V in gastric and colorectal cancer patients in Korea.韩国胃癌和结直肠癌患者中E-钙黏蛋白基因(CDH1)的T340A和L599V变体
Gut. 2000 Aug;47(2):262-7. doi: 10.1136/gut.47.2.262.
7
CDH1 Gene and Hereditary Diffuse Gastric Cancer Syndrome: Molecular and Histological Alterations and Implications for Diagnosis And Treatment.CDH1基因与遗传性弥漫性胃癌综合征:分子与组织学改变及其对诊断和治疗的意义
Front Pharmacol. 2018 Dec 5;9:1421. doi: 10.3389/fphar.2018.01421. eCollection 2018.
8
Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.CDH1 种系突变患者中遗传性弥漫性胃癌检测标准和结果的准确性。
Gastroenterology. 2015 Oct;149(4):897-906.e19. doi: 10.1053/j.gastro.2015.06.003. Epub 2015 Jun 11.
9
Panel testing reveals nonsense and missense CDH1 mutations in families without hereditary diffuse gastric cancer.基因检测显示,在无遗传性弥漫性胃癌的家族中存在CDH1基因的无义突变和错义突变。
Mol Genet Genomic Med. 2016 Jan 13;4(2):232-6. doi: 10.1002/mgg3.197. eCollection 2016 Mar.
10
E-Cadherin (CDH1) and p53 rather than SMAD4 and Caspase-10 germline mutations contribute to genetic predisposition in Portuguese gastric cancer patients.E-钙黏蛋白(CDH1)和p53而非SMAD4和半胱天冬酶-10种系突变导致葡萄牙胃癌患者的遗传易感性。
Eur J Cancer. 2004 Aug;40(12):1897-903. doi: 10.1016/j.ejca.2004.04.027.

引用本文的文献

1
Matching traditional Chinese medicine and western medicine-based research: Advanced nutraceutical development for proactive gastric cancer prevention.中西医结合研究:用于积极预防胃癌的先进营养保健品开发。
World J Gastrointest Oncol. 2024 Sep 15;16(9):3798-3819. doi: 10.4251/wjgo.v16.i9.3798.
2
Lifestyles, genetics, and future perspectives on gastric cancer in east Asian populations.东亚人群胃癌的生活方式、遗传学和未来展望。
J Hum Genet. 2021 Sep;66(9):887-899. doi: 10.1038/s10038-021-00960-8. Epub 2021 Jul 16.
3
Geographical Distribution of E-cadherin Germline Mutations in the Context of Diffuse Gastric Cancer: A Systematic Review.弥漫性胃癌背景下E-钙黏蛋白种系突变的地理分布:一项系统评价
Cancers (Basel). 2021 Mar 12;13(6):1269. doi: 10.3390/cancers13061269.

本文引用的文献

1
Associations of CDH1 germline variant location and cancer phenotype in families with hereditary diffuse gastric cancer (HDGC).CDH1 种系变异位置与遗传性弥漫型胃癌(HDGC)家族中癌症表型的关联。
J Med Genet. 2019 Jun;56(6):370-379. doi: 10.1136/jmedgenet-2018-105361. Epub 2019 Feb 11.
2
Profiling cancer-associated genetic alterations and molecular classification of cancer in Korean gastric cancer patients.韩国胃癌患者癌症相关基因改变分析及癌症分子分类
Oncotarget. 2017 Jul 22;8(41):69888-69905. doi: 10.18632/oncotarget.19435. eCollection 2017 Sep 19.
3
Panel testing reveals nonsense and missense CDH1 mutations in families without hereditary diffuse gastric cancer.基因检测显示,在无遗传性弥漫性胃癌的家族中存在CDH1基因的无义突变和错义突变。
Mol Genet Genomic Med. 2016 Jan 13;4(2):232-6. doi: 10.1002/mgg3.197. eCollection 2016 Mar.
4
Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond.遗传性弥漫性胃癌综合征:CDH1 突变及其他。
JAMA Oncol. 2015 Apr;1(1):23-32. doi: 10.1001/jamaoncol.2014.168.
5
Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers.遗传性弥漫性胃癌:强调种系CDH1突变携带者的最新临床指南
J Med Genet. 2015 Jun;52(6):361-74. doi: 10.1136/jmedgenet-2015-103094. Epub 2015 May 15.
6
Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment.临床评估多基因测序 panel 用于遗传性癌症风险评估。
J Clin Oncol. 2014 Jul 1;32(19):2001-9. doi: 10.1200/JCO.2013.53.6607. Epub 2014 Apr 14.
7
Multiplex genetic cancer testing identifies pathogenic mutations in TP53 and CDH1 in a patient with bilateral breast and endometrial adenocarcinoma.多重基因癌症检测在一名双侧乳腺和子宫内膜腺癌患者中鉴定出 TP53 和 CDH1 的致病性突变。
BMC Med Genet. 2013 Dec 29;14:129. doi: 10.1186/1471-2350-14-129.
8
The importance of E-cadherin binding partners to evaluate the pathogenicity of E-cadherin missense mutations associated to HDGC.E-钙黏蛋白结合伴侣对于评估与 HDGC 相关的 E-钙黏蛋白错义突变的致病性的重要性。
Eur J Hum Genet. 2013 Mar;21(3):301-9. doi: 10.1038/ejhg.2012.159. Epub 2012 Aug 1.
9
Frequency of CDH1 germline mutations in gastric carcinoma coming from high- and low-risk areas: metanalysis and systematic review of the literature.高发和低发地区胃癌中 CDH1 种系突变的频率:荟萃分析和文献系统综述。
BMC Cancer. 2012 Jan 6;12:8. doi: 10.1186/1471-2407-12-8.
10
Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancers.胚系 CDH1 基因突变在早发性或家族性乳腺小叶癌女性中罕见。
J Med Genet. 2011 Jan;48(1):64-8. doi: 10.1136/jmg.2010.079814. Epub 2010 Oct 4.